Manuel Requena Shares The Results of the RESISTANT International Registry
Manuel Requena, Interventional Neurologist at Vall d’Hebron Barcelona Hospital Campus, shared in LinkedIn:
”I am pleased to share the results of the RESISTANT International Registry, recently published in Stroke: Vascular and Interventional Neurology, evaluating intracranial stenting during acute endovascular therapy for ischemic stroke.
I am deeply grateful to all the investigators, interventional teams, and stroke centers worldwide whose collaboration, commitment, and expertise made the RESISTANT registry possible.
This study reflects the power of international collaboration in advancing stroke care.
Together, we collected the largest cohort of patients who underwent acute intracranial stenting (876 patients across 36 international centers).
Key findings:
1. Acute intracranial stenting proved feasible and effective, achieving successful reperfusion (eTICI 2b–3) in nearly 90% of cases.
2. 41% of patients achieved good functional outcomes (mRS 0–2) at 90 days, despite the complexity of these challenging scenarios.
3. Final successful reperfusion and a lower number of thrombectomy attempts before stenting were the strongest predictors of favorable outcomes.
4. Reocclusion occurred in a minority of cases, mostly within the first 48 hours, and no independent predictors of symptomatic intracranial hemorrhage were identified.
Some substudies will be published very soon and we are working on new ones.”
Read the full article here.
Article: Intracranial Stenting During Acute Endovascular Therapy of Stroke: Clinical and Radiological Outcomes of the RESISTANT International Registry
Authors: Manuel Requena, Marta Olivé-Gadea, Francesco Diana, Johannes Kaesmacher, Adnan Mujanovic, Serdar Geyik, Songul Senadim, Alejandro Tomasello
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 26, 2026, 16:40Elena Torre: Rethinking Iron Management in Polycythemia Vera
-
Oct 26, 2026, 16:31Tara King: Building Connections in Transfusion Medicine at AABB
-
Oct 26, 2026, 16:16Wendy Jean Schell: How Genetics and Supplements May Influence Bleeding Risk
-
Oct 26, 2026, 15:37Sally Mandour: Lupus Anticoagulant-The Tree Key Diagnostic Criteria
-
Oct 26, 2026, 15:37Aryabhatta Sadhu: Intrauterine Red-Cell and Platelet Transfusion in Fetal Medicine
-
Oct 26, 2026, 15:25Christine Tunkl: Telestroke – Expanding Access to Evidence-Based Stroke Care
-
Oct 26, 2026, 15:13Heghine Khachatryan: Approaching Thrombocytopenia Through Mechanism and Clinical Context
-
Oct 26, 2026, 15:03Quentin Eichbaum։ AABB 2026 Annual Meeting Personal Highlights
-
Oct 26, 2026, 14:57A Father’s Marathon Journey Inspired by His Son – National Bleeding Disorders Foundation